Table 1 of
Cullinan, Mol Vis 2004;
10:315-322.Table 1 of
Cullinan, Mol Vis 2004;
10:315-322.
Table 1. Quantification of BrdU analysis
The percentages of normal and cytokine-treated Y79 and Weri Rb-1 cells in various phases of the cell cycle were determined by FACS analysis. An example of the FACS data is shown in Figure 4.
Cell Type Treatment %G0/G1 %S %G2/M --------- ------------- ------ ---- ----- Y79 Untreated 42.1 20.6 28.1 Y79 50 ng IFN-γ 45.5 19.1 18.7 Y79 50 ng TNF-α 38.2 21.3 29.6 Y79 50 ng of each 37.2 18.2 23.1 Weri Rb-1 Untreated 30.3 28.7 29.1 Weri Rb-1 50 ng IFN-γ 24.8 29.2 34.0 Weri Rb-1 50 ng TNF-α 31.9 27.9 21.2 Weri Rb-1 50 ng of each 26.1 22.3 21.5 |